Pharmaceutical resources
Press release
April 28, 2014
Anoro™ Ellipta® now available in the US for treatment of COPD
Full prescribing information
ANORO™ ELLIPTA™ (umeclidinium, vilanterol) Full Prescribing Information (PDF - 766,8KB)Multimedia
ANORO™ ELLIPTA™ Product Photo Side Closed 62.5mcg/25mcg (JPG - 49,9KB) ANORO™ ELLIPTA™ Product Photo Front Closed 62.5mcg/25mcg (JPG - 49,6KB) ANORO™ ELLIPTA™ Product Photo Front Open 62.5mcg/25mc (JPG - 97,5KB)Press release
January 26, 2015
GSK expands its portfolio of medicines in the US for patients with asthma and COPD
Multimedia
Arnuity™ Ellipta® 200 mcg (JPG - 41,5KB) Arnuity™ Ellipta® 100 mcg (JPG - 41,5KB) Incruse® Ellipta® Closed 62.5 mcg (PNG - 8,6MB) Incruse® Ellipta® Open 62.5 mcg (JPG - 49,6KB)Press release
August 5, 2020
Press release
Infographics
Background information for BLENREP (Belantamab Mafodotin Blmf) (PDF - 996,0KB) What is Multiple Myeloma? (PDF - 1,0MB)Press release
October 30, 2013
BREO® ELLIPTA™ now available in the U.S. for the treatment of COPD
Full prescribing information
BREO ELLIPTA Full US Prescribing Information (PDF - 1,1MB)Multimedia
BREO ELLIPTA Product Photo Inhaler Open (PNG - 796,2KB) BREO ELLIPTA Product Photo Carton + Inhaler Open (PNG - 1,2MB) BREO ELLIPTA Product Photo Carton + Inhaler Closed (PNG - 1,0MB)Press release
November 4, 2015
GSK’s Nucala® (mepolizumab) receives approval from US FDA
Full prescribing information
NUCALA® (mepolizumab) Full Prescribing Information (PDF - 249,4KB)Infographics
Role of the eosinophil in severe asthma (JPG - 485,5KB)Multimedia
NUCALA® (mepolizumab) 100mg Carton Product Photo (PNG - 6,0MB) NUCALA® (mepolizumab) 100mg Carton & Vial Product Phot (PNG - 5,9MB) NUCALA® (mepolizumab) 100mg Vial Product Photo (PNG - 295,3KB)Press release
September 20, 2017
GSK and Innoviva report positive headline results from IMPACT study showing single inhaler triple therapy Trelegy Ellipta reduced COPD exacerbations
Multimedia
IMPACT Study infographic (PDF - 267,1KB)Press releases
April 24, 2018
Once-daily Trelegy Ellipta gains expanded indication in the US for the treatment of patients with COPD
April 18, 2018
Landmark IMPACT study published in NEJM shows significant benefits of Trelegy Ellipta for patients with COPD
September 18, 2017
Trelegy ELLIPTA approved as the first once-daily single inhaler triple therapy for the treatment of appropriate patients with COPD in the US
Full prescribing information
Trelegy ELLIPTA Full Prescribing Information (PDF - 873,4KB)Multimedia
Trelegy ELLIPTA Factsheet (PDF - 164,9KB) GSK Commitment to COPD Care (PDF - 374,5KB) Trelegy ELLIPTA Product Photo Cap Closed (PNG - 16,9MB) Trelegy ELLIPTA Product Photo Cap Open (PNG - 377,1KB) Trelegy IMPACT study infographic (PDF - 365,8KB)
Press release
April 29, 2020
Press release
Infographics
About Ovarian Cancer (PDF - 194,8KB) PARP Inhibitor Mechanism of Action (PDF - 187,7KB) PRIMA Trial Backgrounder (PDF - 653,6KB)Vaccine resources
Full US prescribing information
FLULAVAL QUADRIVALENT Full US Prescribing Information (PDF - 379,1KB) FLUARIX QUADRIVALENT Full US Prescribing Information (PDF - 561,3KB)Multimedia
FLULAVAL QUADRIVALENT 0.5mL dose packaging (PNG - 369,9KB) FLULAVAL QUADRIVALENT 5mL vial packaging (PNG - 333,2KB) FLUARIX QUADRIVALENT 0.5mL dose packaging (PNG - 1,1MB)Multimedia
Help Protect Yourself and Others Against the Flu (PDF - 270,6KB)For more information about flu, visit flu.gsk.com.
Press release
Date
Shingrix approved in the US for prevention of shingles in adults aged 50 and over
Multimedia
Shingrix multi-dose box and vials (JPG - 175,2KB) Shingrix single-dose box and vials 1 (JPG - 173,9KB) Shingrix single-dose box and vials 2 (JPG - 189,2KB) Shingrix media fact sheet (PDF - 209,0KB) Adjuvants and Waning Adult Immunity - media infographic (PDF - 332,9KB)Press release
November 14, 2017
New survey shines light on critical gaps in adult vaccination knowledge
Executive summary
Vaccinate for Life executive summary (PDF - 313,2KB)Infographic
Vaccinate for Life infographic (PDF - 327,0KB)General resources
Press release
June 11, 2015
Partnership to help communities protect and care for children impacted by disasters
